Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers
Event Calendar

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Event Calendar
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Jeff Greene

Advertisement

Articles by Jeff Greene

Lessons Learned from the Multichannel Shakeout

ByJeff Greene
December 5th 2017

Pharmaceutical Executive

Innovation by itself won't solve the complex multichannel challenges pharmas face.

Advertisement

Latest Updated Articles

  • Lessons Learned from the Multichannel Shakeout
    Lessons Learned from the Multichannel Shakeout

    December 5th 2017



Advertisement
Advertisement

Trending on PharmExec

1

FDA Pannel Votes to Loosen Restrictions for Four Peptides

2

Pharmaceutical Executive Daily: FDA Votes to Reduce Restrictions on Four Peptides

3

President Trump Announces Phased Generic Drug Tariff Plan: Report

4

The Business Case for Employer-Based GLP-1 Coverage

5

Retatrutide Delivers Up to 22.6% Weight Loss in Two New Phase III Trials

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us